Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Oktober 2021

Biotek-snakken — Oktober 2021

Planlagt Fastgjort Låst Flyttet Biotek-snakken
168 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • SolsenS Offline
    SolsenS Offline
    Solsen
    wrote on sidst redigeret af
    #103

    Anavex har har en meget seværdig cc i dag. Så til dem der interesserer sig for dem. Besøg deres hjemmeside og se Dowsonjames cc. De kom bl.a. frem at Blarcamesine kan prissættes til mellem 200-600 k usd årligt. Så alene t Rett er der blogbusterpotentiale. NB Kunne desværre ikke lægge indlæg ind i tråden med Anavex ..

    1 Reply Last reply
    0
    • F Offline
      F Offline
      Fandel
      wrote on sidst redigeret af
      #104

      Godmorgen...

      1 Reply Last reply
      0
      • F Offline
        F Offline
        Fandel
        wrote on sidst redigeret af
        #105

        Er med Solsen. Mega spændende...

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #106

          To this end, Abbott rates ZYME an Overweight (i.e. Buy) and gives it a $56 price target, suggesting a huge 133% one-year upside potential.

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #107

            Link Preview Image
            Wells Fargo: These 3 Stocks Are Poised to Surge by at Least 40%

            Inflation worries seem to be at the forefront of investors’ concerns right now. However, Mark Smith, senior vice president and portfolio manager at Wells Fargo Advisors, has a solution to put investors at ease: “One of the best ways to combat inflation is through buying equities.” The reopening is “on strong,” people have more money than they ever had, and the banks have kicked off the latest earnings season in style - all are reasons to be “extremely bullish," according to Smith. With this in m

            favicon

            Yahoo Finance (finance.yahoo.com)

            1 Reply Last reply
            0
            • F Offline
              F Offline
              Fandel
              wrote on sidst redigeret af
              #108

              Cantargia rapporterar behandling av första patienten i kliniska studien CESTAFOUR

              1 Reply Last reply
              0
              • B Offline
                B Offline
                BioShare
                wrote on sidst redigeret af
                #109

                Tak Sukkeralf - men lige lidt hjælper det. Det vender forhåbentlig rundt. God weekend hele vejen rundt 🙂

                1 Reply Last reply
                0
                • R Offline
                  R Offline
                  Rasbom
                  wrote on sidst redigeret af
                  #110

                  Fandel det hjalp desværre ikke meget på kursen. Det ser ud til en hver nyhed bare benyttes til at øge udsalget….

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #111

                    Netop opskriften på at gøre små investorer trætte af aktien. Hold ud 🙂

                    1 Reply Last reply
                    0
                    • F Offline
                      F Offline
                      Fandel
                      wrote on sidst redigeret af
                      #112

                      Godmorgen...

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        DevOp
                        wrote on sidst redigeret af
                        #113

                        ATNF: CEO Jim Woody forventer at kunne offentliggøre resultater for Dupuytrens's i Dec (måske 10. dec? :-)) og spændende nyt samarbejde med Celltrion

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #114

                          Best Stocks To Invest In Right Now? 3
                          Health Care Stocks To Watch https://www.proinvestor.com/investornyt/722665/best-stocks-to-invest-in-right-now-3-health-care-stocks-to-watch

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #115

                            2 Biotech Stocks That Could Go Parabolic This Week https://www.proinvestor.com/investornyt/722667/2-biotech-stocks-that-could-go-parabolic-this-week

                            1 Reply Last reply
                            0
                            • F Offline
                              F Offline
                              Fandel
                              wrote on sidst redigeret af
                              #116

                              Godmorgen...

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                Pharmafar
                                wrote on sidst redigeret af
                                #117

                                Link Preview Image
                                Novartis top-line results for CANOPY-1 Phase III study support further evaluation of canakinumab in lung cancer

                                favicon

                                Novartis (www.novartis.com)

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  LP90
                                  wrote on sidst redigeret af
                                  #118

                                  er det shorts der sættes i Cantargia skal godt nok love for den er blevet trykket ned den sidste lange tid ?

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Rasbom
                                    wrote on sidst redigeret af
                                    #119

                                    Novartis fejler Igen med Canakinomab. Der bliver helt sikkert ikke meget at juble over som Cantargia aktionær i dag.

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Rasbom
                                      wrote on sidst redigeret af
                                      #120

                                      reuters.com

                                      favicon

                                      (www.reuters.com)

                                      1 Reply Last reply
                                      0
                                      • L Offline
                                        L Offline
                                        LP90
                                        wrote on sidst redigeret af
                                        #121

                                        Rasbom Cantargias can 04 og can 10 kan man vel ikke bare sammenligne med med Novartis eller ?

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #122

                                          IL-1rap er en bredere virkningsmekanisme (hæmmer både Il-1 alfa og IL-1 beta, men stadig ikke godt at Novartis fejler med IL-1 beta

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper